Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case Report

Treatment-resistant schizophrenia (TRS) poses significant therapeutic challenges due to persistent symptoms, poor adherence, and high relapse rates. Long-acting injectable (LAI) antipsychotics offer a promising approach, yet limited evidence exists regarding the combination of two LAI formulations....

Full description

Saved in:
Bibliographic Details
Main Authors: Salvatore Cipolla, Flora Delli Carpini, Pierluigi Catapano, Valeria De Santis, Antonio Volpicelli, Francesco Perris, Francesco Catapano
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/15/3/55
Tags: Add Tag
No Tags, Be the first to tag this record!